<!DOCTYPE html>



<html lang="en">



	<meta charset="UTF-8">

	<meta name="viewport" content="width=device-width, initial-scale=1.0">

	<style>


    .node {

        stroke: #fff;

        stroke-width: 2px;

    }

    

    .link {

        stroke: #777;

        stroke-width: 2px;

    }



</style>

<body>

<a href="https://riskrunners.com">Home</a><br>




<a href="#risk_factors">Jump to Risk Factors</a><br>



<a href="#industry">Jump to Industries</a><br>


<a href="#exposure">Jump to Exposures</a><br>


<a href="#event_code">Jump to Event Codes</a><br>


<a href="#wiki">Jump to Wiki Summary</a><br><br>


    <script src="https://d3js.org/d3.v3.min.js"></script>

    <script>


// set a width and height for our SVG

var width = 3000,


    height = 3000;

    
// setup links

var links =     [
{source: "START_HERE", target: "2: investment", fill: "#fb607f"},
{source: "2: investment", target: "2: common stock involves", fill: "#fb607f"},
{source: "2: investment", target: "3: carefully", fill: "#6f00ff"},
{source: "3: carefully", target: "3: following risk factors", fill: "#6f00ff"},
{source: "3: following risk factors", target: "3: investment", fill: "#6f00ff"},
{source: "3: investment", target: "3: common stock", fill: "#6f00ff"},
{source: "3: carefully", target: "5: following risks actually", fill: "#48d1cc"},
{source: "5: following risks actually", target: "5: financial condition", fill: "#48d1cc"},
{source: "5: financial condition", target: "5: operations could", fill: "#48d1cc"},
{source: "5: operations could", target: "5: materially", fill: "#48d1cc"},
{source: "5: materially", target: "5: adversely affected", fill: "#48d1cc"},
{source: "5: following risks actually", target: "8: previous years", fill: "#8601af"},
{source: "8: previous years", target: "8: use significant amounts", fill: "#8601af"},
{source: "8: use significant amounts", target: "8: operations", fill: "#8601af"},
{source: "8: operations", target: "8: which could", fill: "#8601af"},
{source: "8: previous years", target: "10: businesses", fill: "#367588"},
{source: "10: businesses", target: "10: emerging markets", fill: "#367588"},
{source: "10: emerging markets", target: "10: highly competitive", fill: "#367588"},
{source: "10: businesses", target: "14: additional", fill: "#fdfd96"},
{source: "14: additional", target: "14: financings", fill: "#fdfd96"},
{source: "14: financings", target: "14: combination", fill: "#fdfd96"},
{source: "14: additional", target: "18: eprescribing solutions", fill: "#c19a6b"},
{source: "18: eprescribing solutions", target: "18: services which would prevent us from", fill: "#c19a6b"},
{source: "18: eprescribing solutions", target: "21: eprescribing service", fill: "#900"},
{source: "21: eprescribing service", target: "21: emerging market", fill: "#900"},
{source: "21: eprescribing service", target: "22: market will", fill: "#ffa6c9"},
{source: "22: market will", target: "22: sufficiently", fill: "#ffa6c9"},
{source: "22: sufficiently", target: "22: PocketScript ", fill: "#ffa6c9"},
{source: "22: market will", target: "26: significant", fill: "#009f6b"},
{source: "26: significant", target: "26: PocketScript ", fill: "#009f6b"},
{source: "26: significant", target: "32: revenue from prescription transaction fees from", fill: "#f5f5f5"},
{source: "32: revenue from prescription transaction fees from", target: "32: others with respect", fill: "#f5f5f5"},
{source: "32: others with respect", target: "32: electronic", fill: "#f5f5f5"},
{source: "32: electronic", target: "32: prescriptions processed through", fill: "#f5f5f5"},
{source: "32: prescriptions processed through", target: "32: eprescribing service", fill: "#f5f5f5"},
{source: "32: revenue from prescription transaction fees from", target: "33: Increasing ", fill: "#69359c"},
{source: "33: Increasing ", target: "33: active physician user base", fill: "#69359c"},
{source: "33: active physician user base", target: "33: increasing prescription transaction fees", fill: "#69359c"},
{source: "33: increasing prescription transaction fees", target: "33: profitability", fill: "#69359c"},
{source: "33: profitability", target: "33: eprescribing", fill: "#69359c"},
{source: "33: Increasing ", target: "68: Furthermore ", fill: "#ffc1cc"},
{source: "68: Furthermore ", target: "68: pressures reduced margins", fill: "#ffc1cc"},
{source: "68: pressures reduced margins", target: "68: market acceptance", fill: "#ffc1cc"},
{source: "68: market acceptance", target: "68: which could harm", fill: "#ffc1cc"},
{source: "68: Furthermore ", target: "START_HERE", fill: "#ffc1cc"}]; 
    // create empty nodes array
    var nodes = {};
	var colorFill = [];
	
    // compute nodes from links data
    links.forEach(function(link) {
        link.source = nodes[link.source] ||
            (nodes[link.source] = {name: link.source});
        link.target = nodes[link.target] ||
            (nodes[link.target] = {name: link.target});
		colorFill.push({name: link.source.name, fill: link.fill });
		colorFill.push({name: link.target.name, fill: link.fill });
    });
	
	console.log(colorFill);


    // add a SVG to the body for our viz
    var svg=d3.select('body').append('svg')
        .attr("viewBox", "0 0 " + width + " " + height );

    // use the force
    var force = d3.layout.force()
		.charge(-5000)
		.gravity(0.3)
        .size([width, height])
        .nodes(d3.values(nodes))
        .links(links)
        .on("tick", tick)
        .linkDistance(200)
        .start();

    // add links
    var link = svg.selectAll('.link')
        .data(links)
        .enter().append('line')
        .attr('class', 'link'); 

    // add nodes
    var node = svg.selectAll('.node')
        .data(force.nodes())
        .enter().append('circle')
        .attr('class', 'node')
        .attr('r', width * 0.0035)
		.style("fill", function(d) {
									for (var i = 0; i < colorFill.length; i++) {
										//console.log(d.name);
										if(colorFill[i].name == d.name){
											console.log(colorFill[i].fill);
											return colorFill[i].fill;
										}
									} return "#555";
									
									});
	var label = svg.selectAll(null)
		.data(force.nodes())
		.enter()
		.append("text")
		.text(function (d) { return d.name; })
		.style("text-anchor", "middle")
		.style("fill", "#555")
		.style("font-family", "Arial")
		.style("font-size", 34);


    // what to do 
    function tick(e) {
        
        node.attr('cx', function(d) { return d.x = Math.max(6, Math.min(width - 6, d.x)); })
            .attr('cy', function(d) { return d.y = Math.max(6, Math.min(height - 6, d.y)); })
            .call(force.drag);
            
        link.attr('x1', function(d) { return d.source.x; })
            .attr('y1', function(d) { return d.source.y; })
            .attr('x2', function(d) { return d.target.x; })
            .attr('y2', function(d) { return d.target.y; });
		
		label.attr("x", function(d){ return d.x; })
             .attr("y", function (d) {return d.y - 10; });
        
    }
    
</script><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='industry'>Industries</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Investment Banking and Brokerage</td>
    </tr>
    <tr>
      <td>Electronic Equipment and Instruments</td>
    </tr>
    <tr>
      <td>Health Care Facilities</td>
    </tr>
    <tr>
      <td>Health Care Supplies</td>
    </tr>
    <tr>
      <td>Health Care</td>
    </tr>
    <tr>
      <td>Health Care Equipment and Services</td>
    </tr>
    <tr>
      <td>Managed Health Care</td>
    </tr>
    <tr>
      <td>Health Care Distribution and Services</td>
    </tr>
    <tr>
      <td>Trading Companies and Distributors</td>
    </tr>
    <tr>
      <td>Technology Hardware Storage and Peripherals</td>
    </tr>
    <tr>
      <td>Information Technology</td>
    </tr>
    <tr>
      <td>Technology Hardware and Equipment</td>
    </tr>
    <tr>
      <td>Application Software</td>
    </tr>
    <tr>
      <td>Asset Management and Custody Banks</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='exposure'>Exposures</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Economic</td>
    </tr>
    <tr>
      <td>Military</td>
    </tr>
    <tr>
      <td>Cooperate</td>
    </tr>
    <tr>
      <td>Express intent</td>
    </tr>
    <tr>
      <td>Regime</td>
    </tr>
    <tr>
      <td>Leadership</td>
    </tr>
    <tr>
      <td>Intelligence</td>
    </tr>
    <tr>
      <td>Rights</td>
    </tr>
    <tr>
      <td>Ease</td>
    </tr>
    <tr>
      <td>Judicial</td>
    </tr>
    <tr>
      <td>Crime</td>
    </tr>
    <tr>
      <td>Provide</td>
    </tr>
    <tr>
      <td>Political reform</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='event_code'>Event Codes</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Military blockade</td>
    </tr>
    <tr>
      <td>Solicit support</td>
    </tr>
    <tr>
      <td>Accident</td>
    </tr>
    <tr>
      <td>Agree</td>
    </tr>
    <tr>
      <td>Warn</td>
    </tr>
    <tr>
      <td>Endorse</td>
    </tr>
    <tr>
      <td>Sanction</td>
    </tr>
    <tr>
      <td>Force</td>
    </tr>
    <tr>
      <td>Yield to order</td>
    </tr>
    <tr>
      <td>Sports contest</td>
    </tr>
    <tr>
      <td>Acknowledge responsibility</td>
    </tr>
    <tr>
      <td>Yield</td>
    </tr>
    <tr>
      <td>Host meeting</td>
    </tr>
    <tr>
      <td>Grant</td>
    </tr>
    <tr>
      <td>Threaten</td>
    </tr>
    <tr>
      <td>Demand</td>
    </tr>
    <tr>
      <td>Reward</td>
    </tr>
    <tr>
      <td>Veto</td>
    </tr>
    <tr>
      <td>Yield position</td>
    </tr>
    <tr>
      <td>Psychological state</td>
    </tr>
    <tr>
      <td>Request</td>
    </tr>
    <tr>
      <td>Promise</td>
    </tr>
    <tr>
      <td>Release or return</td>
    </tr>
    <tr>
      <td>Human death</td>
    </tr>
    <tr>
      <td>Reject</td>
    </tr>
    <tr>
      <td>Adjust</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='wiki'>Wiki</th>
      <th>Wiki Summary</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Treasury_stock">Treasury stock</a></td>
      <td>A treasury stock or reacquired stock is stock which is bought back by the issuing company, reducing the amount of outstanding stock on the open market ("open market" including insiders' holdings). \nStock repurchases are used as a tax efficient method to put cash into shareholders' hands, rather than paying dividends, in jurisdictions that treat capital gains more favorably.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Common_stock_dividend">Common stock dividend</a></td>
      <td>A common stock dividend is the dividend paid to common stock owners from the profits of the company.  Like other dividends, the payout is in the form of either cash or stock.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Matthiola_incana">Matthiola incana</a></td>
      <td>Matthiola incana is a species of flowering plant in the cabbage family Brassicaceae. Common names include Brompton stock, common stock, hoary stock, ten-week stock, and gilly-flower.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/New_York_Stock_Exchange">New York Stock Exchange</a></td>
      <td>The New York Stock Exchange (NYSE, nicknamed "The Big Board") is an American stock exchange in the Financial District of Lower Manhattan in New York City. It is by far the world's largest stock exchange by market capitalization of its listed companies at US$30.1 trillion as of February 2018.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Financial_statement">Financial statement</a></td>
      <td>Financial statements (or financial reports) are formal records of the financial activities and position of a business, person, or other entity.\nRelevant financial information is presented in a structured manner and in a form which is easy to understand.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_figures">Significant figures</a></td>
      <td>Significant figures (also known as the significant digits, precision or resolution) of a number in positional notation are digits in the number that are reliable and necessary to indicate the quantity of something.\nIf a number expressing the result of a measurement (e.g., length, pressure, volume, or mass) has more digits than the number of digits allowed by the measurement resolution, then only as many digits as allowed by the measurement resolution are reliable, and so only these can be significant figures.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business-to-business">Business-to-business</a></td>
      <td>Business-to-business (B2B or, in some countries, BtoB) is a situation where one business makes a commercial transaction with another. This typically occurs when:\n\nA business is sourcing materials for their production process for output   (e.g., a food manufacturer purchasing salt), i.e.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Insider">Business Insider</a></td>
      <td>Insider – previously named Business Insider (BI) – is an American financial and business news website founded in 2007. Since 2015, a majority stake in Business Insider's parent company Insider Inc.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Is_Business">Business Is Business</a></td>
      <td>Business-to-business (B2B or, in some countries, BtoB) is a situation where one business makes a commercial transaction with another. This typically occurs when:\n\nA business is sourcing materials for their production process for output   (e.g., a food manufacturer purchasing salt), i.e.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Family_business">Family business</a></td>
      <td>A family business is a commercial organization in which decision-making is influenced by multiple generations of a family, related by blood or marriage or adoption, who has both the ability to influence the vision of the business and the willingness to use this ability to pursue distinctive goals. They are closely identified with the firm through leadership or ownership.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Business_Proposal">Business Proposal</a></td>
      <td>Business Proposal (Korean: 사내 맞선; Hanja: 社內맞선; RR: Sanae Matseon; lit. The Office Blind Date) is a South Korean romantic comedy television series based on the webtoon of the same title written by HaeHwa and illustrated by Narak.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Additional_director_general_of_police">Additional director general of police</a></td>
      <td>Additional Director General of Police (ADGP) is an Indian Police Service rank. Though having the maximum possible 3-star police rank just like Director General of Police,  ADGP's are considered same to DGP's.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Superintendent_of_police_(India)">Superintendent of police (India)</a></td>
      <td>Superintendent of police or SP is a senior rank in Indian Police Service or IPS. Superintendent of Police in Hindi means पुलिस अधीक्षक. They have one Star and one Ashoka emblem on their shoulders and below IPS is written.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Additionality">Additionality</a></td>
      <td>Additionality is the property of an activity being additional by adding something new to the context. It is a determination of whether an intervention has an effect when  compared to a baseline.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Order_of_Australia">Order of Australia</a></td>
      <td>The Order of Australia is an honour that recognises Australian citizens and other persons for outstanding achievement and service. It was established on 14 February 1975 by Elizabeth II, Queen of Australia, on the advice of the Australian Government.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Latin_Extended_Additional">Latin Extended Additional</a></td>
      <td>Latin Extended Additional is a Unicode block.\nThe characters in this block are mostly precomposed combinations of Latin letters with one or more general diacritical marks.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Additional_secretary_to_the_Government_of_India">Additional secretary to the Government of India</a></td>
      <td>Additional Secretary (often abbreviated as AS, GoI or Union Additional Secretary or Additional Secretary to Government of India) is a post and a rank under the Central Staffing Scheme of the Government of India. The authority for creation of this post solely rests with Cabinet of India.Additional secretary is mostly a career civil servant, generally from the Indian Administrative Service, and is a government official of high seniority.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Additional_insured">Additional insured</a></td>
      <td>In insurance policies, an additional insured is a person or organization who enjoys the benefits of being insured under an insurance policy, in addition to whoever originally purchased the insurance policy. The term generally applies within liability insurance and property insurance, but is an element of other policies as well.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Electronic_prescribing">Electronic prescribing</a></td>
      <td>Electronic prescription (e-prescribing or e-Rx) is the computer-based electronic generation, transmission, and filling of a medical prescription, taking the place of paper and faxed prescriptions. E-prescribing allows a physician, physician assistant, pharmacist, or nurse practitioner to use digital prescription software to electronically transmit a new prescription or renewal authorization to a community or mail-order pharmacy.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/LSS_Data_Systems">LSS Data Systems</a></td>
      <td>LSS Data Systems (LSS), was a Minnesota-based medical software and service company that develops products for the physician practice community. LSS was founded in 1982, and since then was a partner of Medical Information Technology (MEDITECH), developing physician practice management and ambulatory electronic health record software.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Pam_Smith">Pam Smith</a></td>
      <td>Pam Smith  is a Professor of Nursing in the School of Health in Social Science at the University of Edinburgh. Her research relates to emotions and care within the nursing profession.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Technological_and_industrial_history_of_21st-century_Canada">Technological and industrial history of 21st-century Canada</a></td>
      <td>The technological and industrial history of Canada encompasses the country's development in the areas of transportation, communication, energy, materials, public works, public services (health care), domestic/consumer and defense technologies. That the 21st century has become the Internet Age is both literal and metaphorical.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Brass_in_Pocket">Brass in Pocket</a></td>
      <td>"Brass in Pocket" is a 1979 single by The Pretenders. It was written by Chrissie Hynde and James Honeyman-Scott, and produced by Chris Thomas.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Monster_in_My_Pocket">Monster in My Pocket</a></td>
      <td>Monster in My Pocket is a media franchise developed by American company Morrison Entertainment Group, headed by Joe Morrison and John Weems, two former senior executives at Mattel.\nThe focus is on monsters and fantastical and legendary creatures from religion, mythology, folklore, fairy tales, literary fantasy, science fiction, cryptids and other anomalous phenomena.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Stones_in_His_Pockets">Stones in His Pockets</a></td>
      <td>Stones in His Pockets is a two-hander written in 1996 by Marie Jones for the DubbleJoint Theatre Company in Dublin, Ireland.\nThe play is a tragicomedy about a small rural town in Ireland where many of the townspeople are extras in a Hollywood film.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Significant_other">Significant other</a></td>
      <td>The term significant other (SO) has different uses in psychology and in colloquial language. Colloquially "significant other" is used as a gender-neutral term for a person's partner in an intimate relationship without disclosing or presuming anything about marital status, relationship status, gender identity, or sexual orientation.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Electronic_music">Electronic music</a></td>
      <td>Electronic music is a genre of music that employs electronic musical instruments, digital instruments, or circuitry-based music technology in its creation. It includes both music made using electronic and electromechanical means (electroacoustic music).</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Electronic_rock">Electronic rock</a></td>
      <td>Electronic rock is a music genre that involves a combination of rock music and electronic music, featuring instruments typically found within both genres. It originates from the late 1960s, when rock bands began incorporating electronic instrumentation into their music.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/EHealth_Ontario">EHealth Ontario</a></td>
      <td>eHealth Ontario is the agency tasked with facilitating the development of Ontario's proposed public Electronic Health Record system.     \nHealth Informatics in Canada is run provincially, with different provinces creating different systems, albeit sometimes under voluntary Pan-Canadian guidelines published by the federal body Canada Health Infoway.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/OpenEMR">OpenEMR</a></td>
      <td>OpenMRS is a collaborative open-source project to develop software to support the delivery of health care in developing countries.OpenMRS is founded on the principles of openness and sharing of ideas, software and strategies for deployment and use. The system is designed to be usable in very resource poor environments and can be modified with the addition of new data items, forms and reports without programming.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Furthermore_(album)">Furthermore (album)</a></td>
      <td>Furthermore is the fifth album led by saxophonist Ralph Moore which was recorded in 1989 and released on the Landmark label.\n\n\n== Reception ==\nIn his review on AllMusic, Stephen Cook stated "Furthermore does not break the mold so much as provide a pleasurable listening experience of the highest order.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/Furthermore:_From_the_Studio,_from_the_Stage">Furthermore: From the Studio, from the Stage</a></td>
      <td>Furthermore: From the Studio, from the Stage is the fifth album of Christian band Jars of Clay.  It was released in 2003 by Essential Records.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/The_Complete_Recordings_(Oh-OK_album)">The Complete Recordings (Oh-OK album)</a></td>
      <td>The Complete Recordings is a compilation album for Oh-OK released by Collector's Choice Music on June 24, 2002. The compilation includes all of the band's previous releases as well as a live set from 1984—shortly before the group broke up.</td>
    </tr>
    <tr>
      <td><a href="https://en.wikipedia.org/wiki/E_(mathematical_constant)">E (mathematical constant)</a></td>
      <td>The number e, also known as Euler's number, is a mathematical constant approximately equal to 2.71828 which can be characterized in many ways. It is the base of the natural logarithms.</td>
    </tr>
  </tbody>
</table><table border="1" class="dataframe">
  <thead>
    <tr style="text-align: right;">
      <th id='risk_factors'>Risk Factors</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>ZIX CORP      Item 1A <font color="blue">Risk Factors </font>         (In these <font color="blue">risk factors</font>, “we,” “us,” “our,” and “ZixCorp” refer to Zix     Corporation and its wholly-owned <font color="blue">subsidiaries</font></td>
    </tr>
    <tr>
      <td>)          An <font color="blue">investment</font> in our <font color="blue"><font color="blue">common stock</font> involves</font> a high degree of risk</td>
    </tr>
    <tr>
      <td>You     should  <font color="blue">carefully</font> consider the following <font color="blue">risk factors</font> in evaluating an     <font color="blue">investment</font> in our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">risks described</font> below are not the only     ones  that we face</td>
    </tr>
    <tr>
      <td>If any of the <font color="blue">following risks actually</font> occurs, our     business, <font color="blue">financial condition</font>, or results of <font color="blue"><font color="blue">operations</font> could</font> be <font color="blue">materially</font>     and <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>In such case, the <font color="blue">trading price</font> of our <font color="blue">common stock</font>     <font color="blue">could decline</font>, and you <font color="blue">could lose</font> all or part of your <font color="blue">investment</font></td>
    </tr>
    <tr>
      <td>You should     also refer to the other information set forth in this report, including our     <font color="blue">consolidated financial statements</font> and the related notes</td>
    </tr>
    <tr>
      <td>We have <font color="blue">incurred <font color="blue">significant</font></font> operating losses in <font color="blue">previous years</font> and we     continue to <font color="blue">use <font color="blue">significant</font> amounts</font> of cash for our business <font color="blue">operations</font>,     <font color="blue">which could</font> result in us having insufficient cash to fund our <font color="blue">operations</font>     under our current business plan</td>
    </tr>
    <tr>
      <td>We have <font color="blue">incurred <font color="blue">significant</font></font> operating losses in <font color="blue">previous years</font></td>
    </tr>
    <tr>
      <td>Our     <font color="blue">businesses</font> operate in <font color="blue"><font color="blue">emerging market</font>s</font> and developing these <font color="blue">businesses</font> is     costly and the market is <font color="blue">highly <font color="blue">competitive</font></font></td>
    </tr>
    <tr>
      <td>Emerging-market <font color="blue">businesses</font> like     ours involve risks and <font color="blue">uncertainties</font>,                                         12       _________________________________________________________________    [45]Table of <font color="blue">Contents       </font>and there are <font color="blue">no assurances</font> that we will be successful in our efforts</td>
    </tr>
    <tr>
      <td>Our liquidity and <font color="blue">capital resources remain</font> limited</td>
    </tr>
    <tr>
      <td>There can be no     assurance that our liquidity or <font color="blue">capital resource position would allow us</font> to     continue to pursue our current business strategy after the <font color="blue">proceeds from</font> the     issuance of our August 2005 private placement are expended</td>
    </tr>
    <tr>
      <td>As a result, we     could be forced to further augment our cash position through <font color="blue">additional</font> cost     reduction measures, sales of assets, <font color="blue">additional</font> <font color="blue">financings</font>, or a <font color="blue">combination</font>     of  these actions</td>
    </tr>
    <tr>
      <td>There is no assurance that we will be able to raise     <font color="blue">additional</font> capital if and when needed or on favorable terms</td>
    </tr>
    <tr>
      <td>If we cannot     <font color="blue">raise capital</font>, we might have to alter our business model</td>
    </tr>
    <tr>
      <td>Any of these     adverse events could <font color="blue">substantially</font> diminish the value of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The  market  may  not  broadly  accept our secure e-messaging and     e-prescribing solutions and services, which would prevent us from operating     profitably</td>
    </tr>
    <tr>
      <td>We must be able to achieve <font color="blue">broad <font color="blue">market <font color="blue">acceptance</font></font></font> for our secure     e-messaging  and e-prescribing solutions and services, at a price that     provides an acceptable rate of <font color="blue">return relative</font> to our costs in order to     operate profitably</td>
    </tr>
    <tr>
      <td>We have not <font color="blue">yet been able</font> to do this</td>
    </tr>
    <tr>
      <td>Furthermore,     PocketScript®, our e-prescribing service, operates in an <font color="blue">emerging market</font></td>
    </tr>
    <tr>
      <td>There is no assurance that this <font color="blue">market will</font> develop <font color="blue">sufficiently</font> to enable     us to operate our <font color="blue">PocketScript </font>business profitably</td>
    </tr>
    <tr>
      <td>There is no assurance     that any of our <font color="blue">services will become generally accepted</font> or that they will be     <font color="blue">compatible with</font> any standards that become generally accepted, nor is there     any assurance that <font color="blue">enough paying users will ultimately</font> be obtained to enable     us to operate these <font color="blue">businesses</font> profitably</td>
    </tr>
    <tr>
      <td>Failure to enter into <font color="blue">additional</font> or to maintain <font color="blue">existing <font color="blue">sponsorship</font></font>     <font color="blue">agreements</font> for our <font color="blue">PocketScript </font>e-prescribing service and generate other     <font color="blue">revenue <font color="blue">opportunities</font> from</font> <font color="blue">PocketScript </font><font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">PocketScript </font>business has <font color="blue">incurred <font color="blue">significant</font></font> operating losses</td>
    </tr>
    <tr>
      <td>Through  <font color="blue">December </font>31,  2005,  <font color="blue">significant</font>  orders for our <font color="blue">PocketScript </font>    e-prescribing service came from <font color="blue">sponsorship</font> <font color="blue">agreements</font> with healthcare     payors</td>
    </tr>
    <tr>
      <td>Under our payor-<font color="blue">sponsorship</font> business model, we deploy <font color="blue">PocketScript </font>    to the end-user physician and provide the end-user physician a <font color="blue">subscription</font>     to use the service in return for <font color="blue">payments from</font> the <font color="blue">healthcare payor</font></td>
    </tr>
    <tr>
      <td><font color="blue">These     </font>payments are in the form of guaranteed <font color="blue">payments from</font> the <font color="blue">healthcare payor</font> or     <font color="blue">contingent payments</font> that are <font color="blue">based on contractually specified performance</font>     metrics</td>
    </tr>
    <tr>
      <td>In  some  cases, these <font color="blue">contingent payments</font> could represent a     substantial  portion  of  the  <font color="blue">revenue opportunity under</font> the contract</td>
    </tr>
    <tr>
      <td><font color="blue">Substantially </font>all of the end-user physicians who are using the <font color="blue">PocketScript </font>    service and for whom we are currently recognizing revenue are doing so under     a <font color="blue">subscription</font> arrangement that has been paid for by a <font color="blue">healthcare payor</font></td>
    </tr>
    <tr>
      <td>Although we believe that <font color="blue">physicians will pay</font> to use the <font color="blue">PocketScript </font>service     following the one year of <font color="blue">service paid</font> for by the <font color="blue">healthcare payor</font>s or that     <font color="blue">healthcare payor</font>s will extend their <font color="blue">sponsorship</font>, there is no assurance that     they will do so</td>
    </tr>
    <tr>
      <td>In addition, we obtain <font color="blue">revenue from <font color="blue">prescription <font color="blue">transaction</font> fees</font> from</font>     pharmacy  benefit  managers  and <font color="blue">others with respect</font> to the <font color="blue">electronic</font>     <font color="blue"><font color="blue">prescriptions</font> processed through</font> our e-prescribing service</td>
    </tr>
    <tr>
      <td><font color="blue">Increasing </font>our     <font color="blue">active <font color="blue">physician user</font> base</font> and <font color="blue">increasing <font color="blue">prescription <font color="blue">transaction</font> fees</font></font> are     critical  to  the  success of our plan to achieve <font color="blue">profitability</font> in our     e-prescribing business</td>
    </tr>
    <tr>
      <td>Failure to sign follow-on orders with <font color="blue">additional</font> <font color="blue">healthcare payor</font>s from     whom  a  <font color="blue">significant</font>  portion of our revenues are received or sign new     <font color="blue">sponsorship</font> <font color="blue">agreements</font> with other payors in the <font color="blue">coming months</font>, or generate     <font color="blue">significant</font> revenue from <font color="blue">contingent payments</font>, or maintain and identify other     revenue  <font color="blue">opportunities</font>  for our e-prescribing services, such as add-on     <font color="blue"><font color="blue">application</font>s</font> or <font color="blue">prescription <font color="blue">transaction</font> fees</font>, and/or new uses for the     <font color="blue">transaction</font> data itself, will prevent us from achieving <font color="blue">significant</font> revenues     from our e-prescribing services</td>
    </tr>
    <tr>
      <td><font color="blue">Healthcare </font><font color="blue">providers may fail</font> to adopt our <font color="blue">PocketScript </font>service</td>
    </tr>
    <tr>
      <td>Our <font color="blue">PocketScript </font>e-prescribing service is targeted to the emerging     market for providing secure <font color="blue"><font color="blue">communication</font>s</font> among healthcare providers to     deliver information in an <font color="blue">efficient</font>, economical manner</td>
    </tr>
    <tr>
      <td>This is an emerging     market, and the success of <font color="blue">PocketScript </font>is <font color="blue">dependent</font>, in large measure, on     physicians  changing the manner in which they <font color="blue">write <font color="blue">prescriptions</font></font></td>
    </tr>
    <tr>
      <td>Our     challenge  is  to make this new business attractive to physicians, and     ultimately, profitable</td>
    </tr>
    <tr>
      <td>To do so has required, and will require, us to     invest <font color="blue">significant</font> resources, including <font color="blue">significant</font> amounts of cash</td>
    </tr>
    <tr>
      <td><font color="blue">There     </font>is no assurance that <font color="blue">enough paying users will ultimately</font> be obtained to     <font color="blue">enable us</font> to operate the <font color="blue">PocketScript </font>business profitably</td>
    </tr>
    <tr>
      <td>13       _________________________________________________________________    [46]Table of <font color="blue">Contents       </font>     Failure to <font color="blue">significant</font>ly increase our base of <font color="blue">PocketScript </font>users or     obtain <font color="blue">significant</font> <font color="blue">prescription <font color="blue">transaction</font> fees</font> may result in failure to     achieve the <font color="blue">critical mass</font> of physicians and revenue to build a successful     business</td>
    </tr>
    <tr>
      <td>We  incur <font color="blue">significant</font> up front costs in <font color="blue"><font color="blue">connection</font> with initially</font>     <font color="blue">establishing</font> our <font color="blue">PocketScript </font>e-prescribing service with the physician     users</td>
    </tr>
    <tr>
      <td>Under our current business model, <font color="blue">third party payors</font> typically pay     all  or a majority of the <font color="blue">variable costs</font> of initially <font color="blue">establishing</font> our     e-prescribing service, and a limited amount of the <font color="blue">overhead costs associated</font>     with our e-prescribing business</td>
    </tr>
    <tr>
      <td>Our plan is to obtain <font color="blue">additional</font> revenues     in the form of recurring annual <font color="blue">subscription</font> fees to use our e-prescribing     service,  either  paid by the <font color="blue">third party payors</font> or the physicians</td>
    </tr>
    <tr>
      <td>In     addition, we must obtain <font color="blue">additional</font> revenues from prescription <font color="blue">transaction</font>     fees to operate this line of business profitably</td>
    </tr>
    <tr>
      <td>As our base of physician     users grows through <font color="blue">additional</font> physicians subscribing to use our service and     the retention of <font color="blue">existing users</font>, we hope to <font color="blue">generate enough revenue</font> to     <font color="blue">become profitable</font> in this line of business</td>
    </tr>
    <tr>
      <td><font color="blue">Increasing </font>our <font color="blue">physician user</font>     base  and <font color="blue">increasing <font color="blue">prescription <font color="blue">transaction</font> fees</font></font> are critical to the     success of this plan</td>
    </tr>
    <tr>
      <td>The  <font color="blue">preponderance</font>  of  the <font color="blue">prescription <font color="blue">transaction</font> fees</font> that we     currently receive are from two pharmacy benefit managers, which manage the     <font color="blue">prescription benefits</font> for their health plan customers, and one <font color="blue">electronic</font>     script aggregator, which receives <font color="blue">scripts written by</font> the <font color="blue">physician user</font> of     our <font color="blue">PocketScript </font>e-prescribing service and transmits them via <font color="blue">electronic</font>     <font color="blue">data interchange</font> to <font color="blue">retail pharmacies</font></td>
    </tr>
    <tr>
      <td>Our contracts with these persons are     short term, meaning that the other <font color="blue">party could cancel</font> the contract and     require us to <font color="blue">renegotiate</font> the <font color="blue">contract at lower fee levels</font> or on other     <font color="blue">unfavorable terms</font> and <font color="blue">conditions</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">unfavorable terms</font> and <font color="blue">conditions</font>     could increase our costs and could require us to revise our business model</td>
    </tr>
    <tr>
      <td>In sum, there is <font color="blue">no assurance as</font> to whether, or how quickly, we will be     able to increase our user base or <font color="blue">prescription <font color="blue">transaction</font> fees</font> to such a     level that would enable this line of business to operate profitably</td>
    </tr>
    <tr>
      <td>If we     are not successful in these <font color="blue">endeavors</font>, we could be required to revise our     business model, exit or reduce the scale of our-e-prescribing business, or     raise <font color="blue">additional</font> capital</td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>in our <font color="blue">businesses</font> is expected to increase, <font color="blue">which could</font>     cause our business to fail</td>
    </tr>
    <tr>
      <td>Our Zix-branded solutions and services are targeted to the secure     e-messaging services market</td>
    </tr>
    <tr>
      <td>Our <font color="blue">PocketScript </font>business is targeted to the     emerging  market  for  <font color="blue">electronic</font>  <font color="blue">prescriptions</font></td>
    </tr>
    <tr>
      <td>As the public’s and     <font color="blue"><font color="blue">government</font>al</font> <font color="blue">authorities</font>’ awareness about the need for privacy and security     of <font color="blue">electronic</font> <font color="blue"><font color="blue">communication</font>s</font> has increased over the past few years, an     increasing number of <font color="blue">competitors</font> have entered the market</td>
    </tr>
    <tr>
      <td>Our  service  offerings  are <font color="blue">focused on</font> the secure     <font color="blue"><font color="blue">communication</font>s</font> market, including secure e-messaging</td>
    </tr>
    <tr>
      <td><font color="blue">Companies </font>that compete     with our Zix-branded secure e-messaging business include <font color="blue">content <font color="blue">management</font></font>     and secure delivery companies, such as Tumbleweed Communications Corp, and     other secure delivery <font color="blue">participants</font>, such as Voltage Security, PostX, PGP     Corporation, Certified Mail, Authentica, and Sigaba Corporation</td>
    </tr>
    <tr>
      <td>In  addition, we <font color="blue">face <font color="blue">competition</font> <font color="blue">from vendors</font></font> of Internet server     appliances, operating systems, networking hardware, network <font color="blue">management</font>     solutions, and <font color="blue">security software</font>, many of which now, or may in the future,     develop or bundle secure e-messaging into their products</td>
    </tr>
    <tr>
      <td>Our  <font color="blue">PocketScript </font> e-prescribing  <font color="blue">service applies</font> the benefits of     e-messaging to the <font color="blue">medical prescription process by enabling providers</font> to     write and transmit <font color="blue">prescriptions</font> <font color="blue">electronic</font>ally directly to the pharmacy</td>
    </tr>
    <tr>
      <td><font color="blue">Participants  </font>in the e-prescribing space include AllScripts <font color="blue">Healthcare </font>    Solutions, MedPlus, Dr</td>
    </tr>
    <tr>
      <td>First, Inc, InstantDX LLC, and iScribe</td>
    </tr>
    <tr>
      <td><font color="blue">Competition </font>    from these companies and <font color="blue">from vendors</font> in related areas, such as <font color="blue">electronic</font>     <font color="blue">medical records vendors</font> — who are expected to include e-prescribing services     as an element of their <font color="blue">service offering</font> — is expected to increase</td>
    </tr>
    <tr>
      <td>We <font color="blue">may face increased <font color="blue">competition</font> as</font> these <font color="blue">competitors</font> partner with     others  or  develop  new  solution and <font color="blue">service offering</font>s to expand the     <font color="blue">functionality</font> that they can offer to their customers</td>
    </tr>
    <tr>
      <td>Our <font color="blue">competitors</font> may,     over time, develop <font color="blue">new <font color="blue">technologies</font></font> that are perceived as being more secure,     <font color="blue">effective</font>,  or  cost  <font color="blue">efficient</font>  than our own</td>
    </tr>
    <tr>
      <td>These <font color="blue">competitors</font> could     <font color="blue"><font color="blue">successfully</font> garner</font> a <font color="blue">significant</font> share of the market, to the exclusion of     our company</td>
    </tr>
    <tr>
      <td>Furthermore, increased <font color="blue">competition</font> could result in pricing     pressures, reduced margins, or the failure of our business to achieve or     maintain <font color="blue">market <font color="blue">acceptance</font></font>, any one of <font color="blue">which could</font> harm our business</td>
    </tr>
    <tr>
      <td>Our <font color="blue">inability</font> to <font color="blue">successfully</font> and timely develop and <font color="blue">introduce new</font>     e-messaging and e-prescribing services and related services and to implement     <font color="blue">technological</font> changes <font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>The  evolving  nature of the secure e-messaging and e-prescribing     <font color="blue">businesses</font> require us to <font color="blue">continually</font> develop and <font color="blue">introduce new</font> and related     solutions  and  services and to improve the performance, features, and     <font color="blue">re<font color="blue">liability</font></font> of our <font color="blue">existing solutions</font> and services, particularly in response     to <font color="blue"><font color="blue">competitive</font> offerings</font></td>
    </tr>
    <tr>
      <td>14       _________________________________________________________________    [47]Table of <font color="blue">Contents       </font>     We have <font color="blue">under development new</font> feature sets for our secure e-messaging     and  e-prescribing <font color="blue">businesses</font></td>
    </tr>
    <tr>
      <td>We may also <font color="blue">introduce new</font> services</td>
    </tr>
    <tr>
      <td>The     success of new or enhanced features and <font color="blue">services <font color="blue">depends on</font> several factors</font>     —  primarily  market  <font color="blue">acceptance</font></td>
    </tr>
    <tr>
      <td>We may not succeed in developing and     <font color="blue">marketing new</font> or enhanced features and services that respond to <font color="blue">competitive</font>     and <font color="blue">technological</font> <font color="blue">developments</font> and changing customer needs</td>
    </tr>
    <tr>
      <td>This <font color="blue">could harm</font>     our business</td>
    </tr>
    <tr>
      <td>If the market for secure e-messaging and e-prescribing services and     related services does not continue to grow, demand for our solutions and     services will be <font color="blue"><font color="blue">adversely</font> affected</font></td>
    </tr>
    <tr>
      <td>The market     for e-prescribing is an <font color="blue">emerging market</font></td>
    </tr>
    <tr>
      <td><font color="blue">Continued </font>growth of the secure     e-messaging and e-prescribing services markets will depend, to a large     extent,  on  the  market  recognizing  the  need for secure <font color="blue">electronic</font>     <font color="blue"><font color="blue">communication</font>s</font>, such as email <font color="blue">encryption</font> and e-prescribing</td>
    </tr>
    <tr>
      <td>Future <font color="blue"><font color="blue">asset impairments</font> could affect</font> our financial results</td>
    </tr>
    <tr>
      <td>On  <font color="blue">September </font>30,  2005,  we  sold our other <font color="blue">MyDocOnline </font>service,     Dr</td>
    </tr>
    <tr>
      <td>Chart, a Web-based <font color="blue">communication</font> tool that <font color="blue">connects healthcare providers</font>     and hospital-based laboratories by allowing doctors to <font color="blue">initiate lab orders</font>,     <font color="blue">check medical necessity compliance</font>, and view results rapidly and <font color="blue">accurately</font>     using  a secure Internet <font color="blue">connection</font></td>
    </tr>
    <tr>
      <td>Chart service     resulted in ZixCorp recognizing a one-time, non-cash loss from the sale in     the <font color="blue">third quarter</font> of 2005 totaling dlra4dtta8 million</td>
    </tr>
    <tr>
      <td>The primary factor in     determining the amount of the loss was the inclusion of the full amount of     <font color="blue">goodwill associated with</font> the purchase of MyDocOnline, totaling dlra4dtta8 million</td>
    </tr>
    <tr>
      <td>As  of <font color="blue">December </font>31, 2005, we have dlra2dtta2 million of <font color="blue">goodwill on</font> our     <font color="blue">balance sheet</font> relating to the <font color="blue">eSecure <font color="blue">product line</font></font></td>
    </tr>
    <tr>
      <td>Goodwill is <font color="blue">evaluated at</font>     least on an <font color="blue">annual basis</font> or <font color="blue">whenever there</font> is a reason to question if the     <font color="blue">goodwill values</font> are impaired</td>
    </tr>
    <tr>
      <td>We also have dlra4dtta2 million of property and     other long-lived assets</td>
    </tr>
    <tr>
      <td>The carrying value of these assets are evaluated     <font color="blue">whenever there</font> is reason to question if the values are impaired</td>
    </tr>
    <tr>
      <td><font color="blue">Future     </font><font color="blue">events could impact</font> the valuation of goodwill and long-lived assets</td>
    </tr>
    <tr>
      <td>It is     possible that we <font color="blue">may incur further charges</font> for other <font color="blue">asset impairments</font> in     the future as we evaluate the prospects of our <font color="blue">various lines</font> of business and     the  use  of  <font color="blue">technologies</font> acquired <font color="blue">by us from <font color="blue">third parties</font> via asset</font>     <font color="blue"><font color="blue">acquisition</font>s</font> in 2003 and 2004</td>
    </tr>
    <tr>
      <td><font color="blue">Capacity </font><font color="blue">limits on</font> our <font color="blue">technology</font> and <font color="blue">network hardware</font> and <font color="blue">software may</font>     be <font color="blue">difficult</font> to project, and we may not be able to expand and/or upgrade our     systems to meet increased use, which would result in <font color="blue">reduced revenues</font></td>
    </tr>
    <tr>
      <td>While we have ample through-put capacity to handle our customers’     <font color="blue">requirements</font>  for the medium term, at some point we may be required to     <font color="blue">materially</font> expand and/or upgrade our <font color="blue">technology</font> and <font color="blue">network hardware</font> and     software</td>
    </tr>
    <tr>
      <td>We may not be able to <font color="blue">accurately</font> project the rate of increase in     usage on our network, particularly since we have <font color="blue">significant</font>ly expanded our     <font color="blue">potential customer base by</font> the <font color="blue">growing use</font> of our <font color="blue">PocketScript </font>service,     which is <font color="blue">supported by</font> our ZixData Center^TM</td>
    </tr>
    <tr>
      <td>In addition, we may not be     able to expand and/or upgrade our systems and <font color="blue">network hardware</font> and software     <font color="blue">capabilities</font> in a <font color="blue">timely manner</font> to <font color="blue">accommodate increased traffic on</font> our     network</td>
    </tr>
    <tr>
      <td>If we do not timely and appropriately expand and/or upgrade our     systems  and  <font color="blue">network hardware</font> and software, we <font color="blue">may lose customers</font> and     revenues</td>
    </tr>
    <tr>
      <td>Security <font color="blue"><font color="blue">interruption</font>s</font> to our <font color="blue"><font color="blue">data centers</font> could disrupt</font> our business,     and any <font color="blue"><font color="blue">security breaches</font> could expose us</font> to <font color="blue">liability</font> and <font color="blue">negatively impact</font>     <font color="blue">customer demand</font> for our solutions and services</td>
    </tr>
    <tr>
      <td>Our business <font color="blue">depends on</font> the <font color="blue">uninterrupted operation</font> of our <font color="blue">data centers</font>     — currently, our <font color="blue">ZixData Center </font>located in Dallas, Texas; and the Austin,     Texas <font color="blue">data center used</font> for fail-over and business <font color="blue">continuity services</font></td>
    </tr>
    <tr>
      <td>We     <font color="blue">must protect</font> these centers from loss, damage, or <font color="blue">interruption</font> caused by     fire, power loss, tele<font color="blue"><font color="blue">communication</font>s</font> failure, or other <font color="blue">events beyond</font> our     control</td>
    </tr>
    <tr>
      <td>Any  damage or failure that causes <font color="blue"><font color="blue">interruption</font>s</font> in our data     centers’ <font color="blue"><font color="blue">operations</font> could</font> <font color="blue">materially</font> harm our business, <font color="blue">financial condition</font>,     and results of <font color="blue">operations</font></td>
    </tr>
    <tr>
      <td>In  addition,  our  ability  to  issue digitally-signed certified     time-stamps and <font color="blue">public <font color="blue">encryption</font> codes</font> in <font color="blue">connection</font> with our Zix-branded     solutions and services and to support the <font color="blue">PocketScript </font>e-prescribing service     <font color="blue">depends on</font> the <font color="blue">efficient</font> operation of the Internet <font color="blue">connection</font>s between     customers and our <font color="blue">data centers</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> Internet <font color="blue">service providers</font>     <font color="blue">efficient</font>ly operating these <font color="blue">connection</font>s</td>
    </tr>
    <tr>
      <td>These providers have experienced     <font color="blue">periodic operational problems</font> or outages in the past</td>
    </tr>
    <tr>
      <td>Any of these problems     or outages could <font color="blue">adversely</font> affect customer <font color="blue">satisfaction</font></td>
    </tr>
    <tr>
      <td>15       _________________________________________________________________    [48]Table of <font color="blue">Contents       </font>     Furthermore, it is critical that our <font color="blue">facilities</font> and <font color="blue">infrastructure</font>     remain  secure and the market perceives them to be secure</td>
    </tr>
    <tr>
      <td>Despite our     <font color="blue">implementation</font> of <font color="blue">network security measures</font>, our <font color="blue">infrastructure</font> may be     vulnerable to physical break-ins, computer viruses, attacks by hackers, and     similar <font color="blue">disruptions from <font color="blue">unauthorized</font> tampering with</font> our <font color="blue">computer systems</font></td>
    </tr>
    <tr>
      <td>In addition, we are vulnerable to <font color="blue">coordinated attempts</font> to overload our     <font color="blue">systems with data</font>, resulting in denial or reduction of service to some or     all  of  our  users for a period of time</td>
    </tr>
    <tr>
      <td>We do not carry insurance to     <font color="blue">compensate us</font> for losses that may occur as a result of any of these events;     therefore, it is possible that we may have to use <font color="blue">additional</font> resources to     address these problems</td>
    </tr>
    <tr>
      <td>Secure <font color="blue">messages sent through</font> our ZixPort^® and ZixMessage Center^TM     messaging  portals,  in  <font color="blue">connection</font>  with  the operation of our secure     e-messaging services, include <font color="blue">personal health</font>care information as well as     personal  financial  information</td>
    </tr>
    <tr>
      <td>This information will reside, for a     user-specified  period of time, in our <font color="blue">secure data center network</font>; and     individual <font color="blue">prescription histories transmitted through</font> our <font color="blue">PocketScript </font>    e-prescribing  system  and  other  <font color="blue">personally identifiable health care</font>     information will reside in our <font color="blue">secure data center network</font></td>
    </tr>
    <tr>
      <td>Federal and state     laws impose <font color="blue">significant</font> financial penalties for <font color="blue">unauthorized</font> <font color="blue">disclosure</font> of     personal information</td>
    </tr>
    <tr>
      <td>Exposure of this information, resulting from any     physical or <font color="blue">electronic</font> break-ins or other <font color="blue">security breaches</font> or <font color="blue">compromises</font>     of this information, could expose us to <font color="blue">significant</font> <font color="blue">liability</font>, and customers     could be reluctant to use our Internet-related services</td>
    </tr>
    <tr>
      <td><font color="blue">Pending  </font><font color="blue"><font color="blue">litigation</font> could</font> have a material <font color="blue">impact on</font> our operating     results and <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td><font color="blue">Beginning </font>in early <font color="blue">September </font>2004, several <font color="blue">purported <font color="blue">shareholder</font></font> class     <font color="blue">action lawsuits</font> were filed in the US District Court for the Northern     District of Texas <font color="blue">against us</font> and certain of our current and <font color="blue">former officers</font>     and <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>The purported class <font color="blue">action lawsuits</font> seek unspecified monetary     damages  on  behalf  of  purchasers  of ZixCorp’s <font color="blue">common stock</font> between     October 30, 2003 and May 4, 2004</td>
    </tr>
    <tr>
      <td>The <font color="blue">purported <font color="blue">shareholder</font></font> class action     lawsuits allege that the <font color="blue">defendants</font> made <font color="blue">materially</font> false and misleading     statements and/or omissions in violation of Sections 10(b) and 20(a) of the     <font color="blue">Securities <font color="blue">Exchange Act</font> </font>of 1934, as amended (the “<font color="blue">Exchange Act</font>”), during     this time period</td>
    </tr>
    <tr>
      <td>Also, three <font color="blue">purported <font color="blue">shareholder</font></font> derivative lawsuits have been filed     <font color="blue">against us</font> and certain of our current and <font color="blue">former officers</font> and <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>The     <font color="blue">shareholder</font> derivative lawsuits relate to the allegedly <font color="blue">materially</font> false and     misleading statements and/or omissions that are the subject of the purported     <font color="blue">shareholder</font> class <font color="blue">action lawsuits</font></td>
    </tr>
    <tr>
      <td>The <font color="blue">derivative lawsuits name</font> ZixCorp as a     <font color="blue">nominal defendant</font> and as actual <font color="blue">defendants</font> the <font color="blue"><font color="blue">individuals</font> named</font> in the     <font color="blue">purported <font color="blue">shareholder</font></font> class <font color="blue">action lawsuits</font> mentioned above and others</td>
    </tr>
    <tr>
      <td>The     suits seek to require ZixCorp to initiate legal action for unspecified     damages against the individual <font color="blue">defendants</font> named in the <font color="blue">purported <font color="blue">shareholder</font></font>     class <font color="blue">action lawsuits</font></td>
    </tr>
    <tr>
      <td>The suits also allege breaches of <font color="blue">fiduciary duty</font>,     abuse of control, insider selling, and <font color="blue">misappropriation</font> of information; and     <font color="blue">seek contribution</font> and <font color="blue"><font color="blue">indemnification</font> against</font> the individual <font color="blue">defendants</font></td>
    </tr>
    <tr>
      <td>These <font color="blue">lawsuits may</font> require <font color="blue">significant</font> <font color="blue">management</font> time and attention     and could result in <font color="blue">significant</font> legal expenses</td>
    </tr>
    <tr>
      <td>While we believe these     lawsuits are <font color="blue">without merit</font> and intend to <font color="blue">defend them vigorously</font>, we are     unable to predict the scope or outcome of these matters and quantify their     <font color="blue">eventual impact</font>, if any, on our company</td>
    </tr>
    <tr>
      <td>An <font color="blue">unfavorable outcome could</font> have a     material adverse effect on our business, operating results, <font color="blue">cash flow</font>, and     <font color="blue">financial condition</font></td>
    </tr>
    <tr>
      <td>We maintain insurance that may limit our financial     exposure for <font color="blue">defense costs</font> and <font color="blue">liability</font> for an unfavorable outcome, should     we not prevail, for claims <font color="blue">covered by</font> the <font color="blue">insurance coverage</font></td>
    </tr>
    <tr>
      <td>We may have to defend our rights in <font color="blue">intellectual property</font> that we use     in our services, <font color="blue">which could</font> be <font color="blue">disruptive</font> and expensive to our business</td>
    </tr>
    <tr>
      <td>We  may have to defend our <font color="blue">intellectual property</font> rights or defend     against claims that we are infringing the rights of others</td>
    </tr>
    <tr>
      <td><font color="blue">Intellectual     </font>property  <font color="blue">litigation</font>  and  <font color="blue">controversies</font> are <font color="blue">disruptive</font> and expensive</td>
    </tr>
    <tr>
      <td><font color="blue">Infringement </font>claims could require us to develop non-infringing services or     enter  into  royalty  or  <font color="blue">licensing <font color="blue">arrangements</font></font></td>
    </tr>
    <tr>
      <td>Royalty or licensing     <font color="blue">arrangements</font>, if required, may not be obtainable on terms acceptable to us</td>
    </tr>
    <tr>
      <td>Our business could be <font color="blue">significant</font>ly harmed if we are not able to develop or     license the <font color="blue">necessary</font> <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>Furthermore, it is possible that others     may in<font color="blue">dependent</font>ly develop <font color="blue">substantially</font> equivalent <font color="blue">intellectual property</font>,     <font color="blue">thus enabling them</font> to <font color="blue">effective</font>ly compete <font color="blue">against us</font></td>
    </tr>
    <tr>
      <td>We subject our solutions and services to <font color="blue">quality assurance testing</font>     prior to release</td>
    </tr>
    <tr>
      <td><font color="blue">Regardless </font>of the <font color="blue">quality assurance testing</font>, any of our     <font color="blue">solutions could contain undetected defects</font> or errors</td>
    </tr>
    <tr>
      <td>In particular, our     <font color="blue">PocketScript </font>system is used to transmit <font color="blue">prescriptions</font></td>
    </tr>
    <tr>
      <td>Defects or errors in     our <font color="blue">PocketScript </font><font color="blue">system could</font> result in inaccurate <font color="blue">prescriptions</font> being     generated, <font color="blue">which could</font> result in injury or death to patients</td>
    </tr>
    <tr>
      <td><font color="blue">Undetected     </font>defects or <font color="blue">errors could</font> result in loss of or delay in revenues, failure to     achieve <font color="blue">market <font color="blue">acceptance</font></font>, diversion of development resources, injury to our     reputation, <font color="blue">litigation</font> claims, increased insurance costs, or increased     service  and  warranty  costs</td>
    </tr>
    <tr>
      <td>Any one of these <font color="blue">could prevent us from</font>     <font color="blue">implementing</font> our business model and achieving the revenues we need to                                         16       _________________________________________________________________    [49]Table of <font color="blue">Contents       </font>operate profitably</td>
    </tr>
    <tr>
      <td>Public key cryptography <font color="blue">technology</font> is subject to risks</td>
    </tr>
    <tr>
      <td>Our  Zix-branded  solutions  and  services  and  the <font color="blue">PocketScript </font>    e-prescribing service employ, and <font color="blue">future solutions</font> and <font color="blue">services may employ</font>,     <font color="blue">public key</font> cryptography <font color="blue">technology</font></td>
    </tr>
    <tr>
      <td>With <font color="blue">public key</font> cryptography <font color="blue">technology</font>,     a <font color="blue">public key</font> and a <font color="blue">private key</font> are used to encrypt and <font color="blue">decrypt messages</font></td>
    </tr>
    <tr>
      <td>The     <font color="blue">security afforded by</font> this <font color="blue">technology</font> depends, in large measure, on the     integrity  of  the  private  key,  which is <font color="blue">dependent</font>, in part, on the     <font color="blue">application</font> of <font color="blue">certain mathematical principles</font></td>
    </tr>
    <tr>
      <td>The integrity of the private     key is <font color="blue">predicated on</font> the <font color="blue">assumption</font> that it is <font color="blue">difficult</font> to <font color="blue">mathematically</font>     derive  the <font color="blue">private key</font> from the related <font color="blue">public key</font></td>
    </tr>
    <tr>
      <td>Should methods be     developed that make it easier to derive the <font color="blue">private key</font>, the security of     <font color="blue">encryption</font>  services using <font color="blue">public key</font> cryptography <font color="blue">technology</font> would be     reduced or eliminated and <font color="blue">such services could become unmarketable</font></td>
    </tr>
    <tr>
      <td><font color="blue">This     </font>could require us to make <font color="blue">significant</font> changes to our services, <font color="blue">which could</font>     damage our reputation and <font color="blue">otherwise hurt</font> our business</td>
    </tr>
    <tr>
      <td>Moreover, there have     been  public reports of the <font color="blue">successful decryption</font> of <font color="blue">certain encrypted</font>     messages</td>
    </tr>
    <tr>
      <td>This or related publicity could <font color="blue">adversely</font> affect public <font color="blue">perception</font>     of the <font color="blue">security afforded by</font> <font color="blue">public key</font> cryptography <font color="blue">technology</font>, <font color="blue">which could</font>     harm our business</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> key personnel</td>
    </tr>
    <tr>
      <td>We <font color="blue">depend on</font> the performance of our <font color="blue">senior <font color="blue">management</font> team</font> — including     our Chairman, CEO, and President, Richard D Spurr, and our Vice President     of Finance and Administration, CFO, and Treasurer, Bradley C Almond, and     their direct reports and other <font color="blue">key employees</font>, particularly highly skilled     <font color="blue">technical personnel</font></td>
    </tr>
    <tr>
      <td>Our success <font color="blue">depends on</font> our ability to attract, retain,     and motivate these <font color="blue">individuals</font></td>
    </tr>
    <tr>
      <td>There are no binding <font color="blue">agreements</font> with any of     our employees that <font color="blue">prevent them from leaving</font> our <font color="blue">company at</font> any time</td>
    </tr>
    <tr>
      <td><font color="blue">There     </font>is <font color="blue">competition</font> for these personnel</td>
    </tr>
    <tr>
      <td>In addition, we do not maintain key     person <font color="blue">life insurance on</font> any of our personnel</td>
    </tr>
    <tr>
      <td>The loss of the services of     any of our <font color="blue">key employees</font> or our failure to attract, retain, and <font color="blue">motivate key</font>     employees <font color="blue">could harm</font> our business</td>
    </tr>
    <tr>
      <td>We <font color="blue">rely on <font color="blue">third parties</font></font></td>
    </tr>
    <tr>
      <td>If <font color="blue">critical services</font> and products that we <font color="blue">source from <font color="blue">third parties</font></font>     were to no longer be made available to us or at a <font color="blue">considerably higher price</font>     than we <font color="blue">currently pay</font> for them, and <font color="blue">suitable <font color="blue">alternatives could</font></font> not be     found, our business could be harmed</td>
    </tr>
    <tr>
      <td>For <font color="blue">certain elements</font> of our <font color="blue">service offering</font>s, we <font color="blue">sometimes rely on</font> the     products and services of <font color="blue"><font color="blue">third parties</font> under contracts</font></td>
    </tr>
    <tr>
      <td>Those <font color="blue">third parties</font>     are  not  under  our <font color="blue">control beyond</font> the terms of their <font color="blue">agreements</font> and,     therefore, should they elect to withhold their products or services or     <font color="blue">significant</font>ly raise their prices, we could be <font color="blue">damaged financially</font> in lower     <font color="blue">returns on sales</font> and a lessening of <font color="blue">competitive</font> advantages if suitable     <font color="blue">alternatives could</font> not be found in a <font color="blue">reasonable period</font> of time</td>
    </tr>
    <tr>
      <td>We could be <font color="blue">affected by <font color="blue">government</font> regulation</font></td>
    </tr>
    <tr>
      <td>Exports of software solutions and services using <font color="blue">encryption</font> <font color="blue">technology</font>,     such as our Zix-branded solutions and services, are <font color="blue">generally restricted by</font>     the US <font color="blue">government</font></td>
    </tr>
    <tr>
      <td>Although we have obtained US <font color="blue">government</font> approval to     export our solutions and services to almost all countries, the list of     countries to which our solutions and <font color="blue">services cannot</font> be <font color="blue">exported could</font> be     revised in the future</td>
    </tr>
    <tr>
      <td>Furthermore, some <font color="blue">countries impose restrictions on</font>     the use of <font color="blue">encryption</font> solutions and services, such as ours</td>
    </tr>
    <tr>
      <td>Failure to     obtain the required <font color="blue"><font color="blue">government</font>al</font> approvals would preclude the sale or use of     our solutions and services in <font color="blue">international</font> markets</td>
    </tr>
    <tr>
      <td>Furthermore, boards of pharmacy in the various states in which our     <font color="blue">PocketScript </font>business operates regulate the <font color="blue">process by which physicians</font>     <font color="blue">write <font color="blue">prescriptions</font></font></td>
    </tr>
    <tr>
      <td>While <font color="blue">regulations</font> in the states in which this business     currently operates <font color="blue">generally permit</font> the <font color="blue">electronic</font> writing of <font color="blue">prescriptions</font>,     such <font color="blue">regulations</font> could be revised in the future</td>
    </tr>
    <tr>
      <td>Moreover, <font color="blue">regulations</font> in     states in which our <font color="blue">PocketScript </font>business does not currently operate may not     be as favorable and may impede our ability to develop business in these     states</td>
    </tr>
    <tr>
      <td>The federal <font color="blue">government</font> has proposed <font color="blue">regulations</font> to create an exception     to the prohibition on physicians’ referrals to <font color="blue">health care entities with</font>     which they have <font color="blue">financial relationships</font> for certain <font color="blue">electronic</font> prescribing     <font color="blue">arrangements</font>, to be codified at 42 CFR §411dtta357(v), and an exception to     the related federal health care anti-kickback rules for certain <font color="blue">electronic</font>     prescribing <font color="blue">arrangements</font>, to be codified at 42 CFR §1001dtta952(x)</td>
    </tr>
    <tr>
      <td>The     purpose  of the proposed <font color="blue">regulations</font> is to <font color="blue">encourage physicians</font> to use     <font color="blue">electronic</font> prescribing systems to create and deliver <font color="blue">prescriptions</font> to the     pharmacy</td>
    </tr>
    <tr>
      <td>The proposed <font color="blue">regulations</font> seek to accomplish this <font color="blue">purpose by</font>     creating <font color="blue">certain safe harbors</font> that are intended to <font color="blue">encourage health care</font>     entities, such as health insurance companies and hospitals, to provide     <font color="blue">financial incentives</font> to physicians to use <font color="blue">electronic</font> prescribing systems</td>
    </tr>
    <tr>
      <td>There is no assurance that the final <font color="blue">regulations</font> will actually encourage the     use of <font color="blue">electronic</font> prescribing systems</td>
    </tr>
    <tr>
      <td>Furthermore, the final <font color="blue">regulations</font>     could provide other <font color="blue">participants</font> in the market a <font color="blue">competitive</font> advantage or     could have <font color="blue">currently unforeseen consequences</font> that harm our business</td>
    </tr>
    <tr>
      <td>17       _________________________________________________________________    [50]Table of <font color="blue">Contents       </font>     Also, future state or <font color="blue">federal regulation could mandate standards</font> for     the  <font color="blue">electronic</font>  writing of <font color="blue">prescriptions</font> or for the secure <font color="blue">electronic</font>     transmittal of <font color="blue">personal health</font> information through the Internet that our     <font color="blue">technology</font> and systems do not <font color="blue">comply with</font>, which would require us to modify     our <font color="blue">technology</font> and systems</td>
    </tr>
    <tr>
      <td>The costs of <font color="blue">compliance could</font> be substantial</td>
    </tr>
    <tr>
      <td>Our <font color="blue">stock price may</font> be volatile</td>
    </tr>
    <tr>
      <td>The <font color="blue">market price</font> of our <font color="blue">common stock</font> has fluctuated <font color="blue">significant</font>ly in     the past and is likely to fluctuate in the future</td>
    </tr>
    <tr>
      <td>Our <font color="blue">stock price may</font>     <font color="blue">decrease as</font> a result of the dilutive effect caused by the <font color="blue">additional</font> number     of shares that <font color="blue">may become available</font> in the <font color="blue">market due</font> to the issuances of     our <font color="blue">common stock</font> in <font color="blue">connection</font> with the <font color="blue">capital funding</font> and <font color="blue">acquisition</font>     <font color="blue"><font color="blue">transaction</font>s</font> we completed over the <font color="blue">last few years</font></td>
    </tr>
    <tr>
      <td><font color="blue">As of <font color="blue">February </font></font>15, 2006,     there was a short position in our <font color="blue">common stock</font> of 3cmam552cmam617 shares, which     may affect the <font color="blue">volatility</font> of our stock price</td>
    </tr>
    <tr>
      <td>One investor owns a large percentage of our <font color="blue">outstanding stock</font> and could     <font color="blue">significant</font>ly influence the outcome of actions</td>
    </tr>
    <tr>
      <td><font color="blue">Haywood     </font><font color="blue">beneficially</font>  own  approximately 11dtta4prca of our outstanding <font color="blue">common stock</font>     (<font color="blue">measured as</font> of <font color="blue">February </font>13, 2006)</td>
    </tr>
    <tr>
      <td>Therefore, Mr</td>
    </tr>
    <tr>
      <td>Haywood <font color="blue">could exert</font>     substantial  influence  over  all  matters  requiring  <font color="blue">approval by</font> our     <font color="blue">shareholder</font>s, including the election of <font color="blue">directors</font></td>
    </tr>
    <tr>
      <td>Haywood’s interests     may  not be <font color="blue">aligned with</font> the interests of our other <font color="blue">shareholder</font>s</td>
    </tr>
    <tr>
      <td><font color="blue">This     </font><font color="blue">concentration</font>  of ownership and <font color="blue">voting power may discourage</font> or prevent     someone from acquiring our business</td>
    </tr>
    <tr>
      <td>We  have a <font color="blue">certain amount</font> of debt and may be unable to service or     refinance this debt, or servicing this <font color="blue">debt may restrict cash available</font> for     our business <font color="blue">operations</font>, or <font color="blue">complying with</font> the covenants of the <font color="blue">debt could</font>     <font color="blue">restrict certain</font> desired business actions</td>
    </tr>
    <tr>
      <td><font color="blue">As of <font color="blue">December </font></font>31, 2005 our total outstanding indebtedness, including     <font color="blue">capital leases</font>, requires us to make payments totaling dlra8dtta1 million payable     over the next two years, excluding interest</td>
    </tr>
    <tr>
      <td>This level of <font color="blue">debt could</font> have     <font color="blue">negative consequences</font></td>
    </tr>
    <tr>
      <td>For example, it could:       •   result in our <font color="blue">inability</font> to <font color="blue">comply with</font> the financial and other     <font color="blue">restrictive covenants</font> in our <font color="blue">outstanding convertible</font> notes, <font color="blue">which among</font>     other things, require us to maintain <font color="blue">specified cash levels</font> and limit our     ability to incur debt and sell assets, <font color="blue">which could</font> in turn result in an     event of default that, if not cured or waived, could have a material adverse     effect on our <font color="blue">operations</font>;         •   require us to dedicate a substantial portion of our <font color="blue">cash flow</font> from     <font color="blue">operations</font> to make <font color="blue">scheduled principal payments on</font> our debt or to meet     required cash reserves, thereby reducing the <font color="blue">availability</font> of our <font color="blue">cash flow</font>     for working capital, capital <font color="blue">investment</font>s, and other business <font color="blue">activities</font>;         •   increase our <font color="blue">vulnerability</font> to <font color="blue">adverse industry</font> and <font color="blue">general economic</font>     <font color="blue">conditions</font>;          •   limit our ability to obtain <font color="blue">additional</font> financing to <font color="blue">fund future</font>     working capital, capital <font color="blue">investment</font>s, and other business <font color="blue">activities</font>;         •   limit our ability to refinance our <font color="blue">indebtedness on terms</font> that are     <font color="blue">commercially reasonable</font>; and          •   limit our <font color="blue">flexibility</font> to plan for, and react to, changes in our     business and our industry</td>
    </tr>
    <tr>
      <td>We have a <font color="blue">significant</font> amount of <font color="blue">convertible securities</font> and related     <font color="blue">warrants outstanding</font> and may issue <font color="blue">additional</font> equity securities in the     future</td>
    </tr>
    <tr>
      <td><font color="blue">Conversion </font>or <font color="blue">redemption</font> of our <font color="blue">outstanding convertible</font> note into     our <font color="blue">common stock</font>, exercise of the <font color="blue">outstanding warrants</font>, and <font color="blue">future issuances</font>     or <font color="blue">conversion</font> of other <font color="blue">securities will dilute</font> the <font color="blue">ownership interests</font> of     existing <font color="blue">shareholder</font>s</td>
    </tr>
    <tr>
      <td>The  outstanding  balance  of our <font color="blue">convertible promissory</font> note was     dlra5dtta0 million at <font color="blue">December </font>31, 2005</td>
    </tr>
    <tr>
      <td>Per the terms of our convertible note,     the full amount outstanding may be converted by the holders at a <font color="blue">conversion</font>     price of dlra5dtta38 per share</td>
    </tr>
    <tr>
      <td>If <font color="blue">fully converted at</font> this price, we could be     obligated  to  issue an <font color="blue">additional</font> 929cmam368 shares of our <font color="blue">common stock</font>,     assuming  <font color="blue">shareholder</font>  approval</td>
    </tr>
    <tr>
      <td>We have <font color="blue">also issued warrants covering</font>     1cmam910cmam834 shares of our <font color="blue">common stock</font> to the current and former holders of     the convertible notes and <font color="blue">additional</font> warrants to purchase 166cmam667 shares of     common  stock  were issued to the <font color="blue">placement agent</font> for the <font color="blue">transaction</font></td>
    </tr>
    <tr>
      <td><font color="blue">Including  </font>these  warrants,  we have <font color="blue">outstanding warrants</font> and options,     including options held by our employees, covering                                         18       _________________________________________________________________    [51]Table of <font color="blue">Contents       </font>approximately 15dtta2 million shares of our <font color="blue">common stock</font> with exercise prices     ranging from dlra1dtta44 to dlra57dtta60</td>
    </tr>
    <tr>
      <td>The issuances of shares of <font color="blue">common stock</font> in respect of the convertible     note and these warrants and <font color="blue">options would</font> result in a substantial voting     dilution of our current <font color="blue">shareholder</font>s</td>
    </tr>
    <tr>
      <td>Any sales in the <font color="blue">public market</font> of the     <font color="blue">common stock</font> issuable upon such <font color="blue">conversion</font> or <font color="blue">redemption</font> of the notes or     exercise of the warrants and options could <font color="blue">adversely</font> affect prevailing     <font color="blue">market price</font>s of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In the future, we may determine to seek <font color="blue">additional</font> <font color="blue">capital funding</font> or     to acquire <font color="blue">additional</font> <font color="blue">businesses</font>, <font color="blue">which could</font> involve the issuance of one or     more types of equity securities, including convertible debt, common and     convertible preferred stock, and warrants to acquire common or preferred     stock</td>
    </tr>
    <tr>
      <td>Such  equity  securities  could  be  issued  at  or  below the     then-prevailing <font color="blue">market price</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>In addition, we incent our     employees and <font color="blue">attract new employees by issuing shares</font> of our <font color="blue">common stock</font>     and options to <font color="blue">purchase shares</font> of our <font color="blue">common stock</font></td>
    </tr>
    <tr>
      <td>The interest of our     existing <font color="blue">shareholder</font>s may be <font color="blue">diluted by</font> any <font color="blue">equity securities issued</font> in     <font color="blue">capital funding</font> <font color="blue">financings</font> or business <font color="blue"><font color="blue">acquisition</font>s</font> and would be <font color="blue">diluted by</font>     any <font color="blue">such future</font> share issuances and <font color="blue">stock option grants</font> to employees</td>
    </tr>
    <tr>
      <td>Finally, as a result of the anti-dilution provisions of the warrants     described above, we may be obligated to <font color="blue">register with</font> the SEC <font color="blue">additional</font>     shares of <font color="blue">common stock</font> issuable to the <font color="blue">warrant holders</font> for <font color="blue">public resale</font></td>
    </tr>
    <tr>
      <td>We may have <font color="blue">liability</font> for <font color="blue">indemnification</font> claims arising from the sale     of our Web Inspector ^^® , Message Inspector ^^® , and Dr</td>
    </tr>
    <tr>
      <td>We disposed of our <font color="blue">Web Inspector and Message Inspector </font><font color="blue"><font color="blue">product line</font>s</font> in     March 2005 and our Dr</td>
    </tr>
    <tr>
      <td>Chart <font color="blue">product line</font> in <font color="blue">September </font>2005</td>
    </tr>
    <tr>
      <td>In selling     those  products, we agreed to provide customary <font color="blue">indemnification</font> to the     purchasers  of  those  <font color="blue">businesses</font>  for breaches of <font color="blue">representations</font> and     warranties, covenants, and other <font color="blue">specified matters</font></td>
    </tr>
    <tr>
      <td><font color="blue">Indemnification </font>claims     could be asserted <font color="blue">against us</font> with respect to these matters</td>
    </tr>
    <tr>
      <td><font color="blue">The Company </font>has     evaluated these <font color="blue">indemnification</font>s and determined that no accrual is currently     <font color="blue">necessary</font></td>
    </tr>
    <tr>
      <td>We <font color="blue">may encounter</font> other risks</td>
    </tr>
    <tr>
      <td>We <font color="blue">may encounter</font> other <font color="blue">unanticipated risks</font> and <font color="blue">uncertainties</font> in the     markets we serve or in developing <font color="blue">new services</font>, and we <font color="blue">cannot give assurance</font>     that we will be successful in responding to any <font color="blue">unanticipated risks</font> or     <font color="blue">uncertainties</font></td>
    </tr>
    <tr>
      <td>There are <font color="blue">no assurances</font> that we will be successful or that we will not     encounter other, and even unanticipated, risks</td>
    </tr>
    <tr>
      <td>We discuss other operating,     financial or <font color="blue">legal risks</font> or <font color="blue">uncertainties</font> in our <font color="blue">periodic filings with</font> the     SEC We are, of course, also subject to <font color="blue">general economic</font> risks</td>
    </tr>
    <tr>
      <td>NOTE ON FORWARD-LOOKING STATEMENTS AND RISK FACTORS            This document contains “forward-looking statements” within the meaning     of Section 27A of the <font color="blue">Securities Act </font>of 1933, as amended (the “Act”) and     Section 21E of the <font color="blue">Exchange Act</font></td>
    </tr>
    <tr>
      <td>All statements other <font color="blue">than statements</font> of     historical fact are “forward-looking statements” for purposes of federal and     state <font color="blue">securities laws</font>, including: any <font color="blue">projections</font> of future business, market     share, earnings, revenues, or other <font color="blue">financial items</font>; any statements of the     plans, strategies, and <font color="blue">objectives</font> of <font color="blue">management</font> for future <font color="blue">operations</font>; any     statements concerning proposed new products, services, or <font color="blue">developments</font>; any     statements  regarding  future  economic <font color="blue">conditions</font> or performance; any     statements of belief; and any statements of <font color="blue">assumption</font>s underlying any of     the foregoing</td>
    </tr>
    <tr>
      <td>Forward-looking <font color="blue">statements may</font> include the words “may,”     “will,”  “predict,”  “project,” “forecast,” “plan,” “should,” “could,”     “goal,” “estimate,” “intend,” “continue,” “believe,” “expect,” “outlook,”     “anticipate,” “hope,” and other similar <font color="blue">expressions</font></td>
    </tr>
    <tr>
      <td>Such forward-looking     <font color="blue">statements may</font> be contained in the “Risk Factors” section above, and the     “Management’s Discussion and Analysis” below, among other places</td>
    </tr>
    <tr>
      <td>Although we believe that the <font color="blue">expectations reflected</font> in any of our     forward-looking statements are reasonable, actual results <font color="blue">could differ</font>     <font color="blue">materially</font> from those projected or assumed in any of our forward-looking     statements</td>
    </tr>
    <tr>
      <td>Our future <font color="blue">financial condition</font> and results of <font color="blue">operations</font>, as     well  as  any forward-looking statements, are subject to change and to     <font color="blue">inherent risks</font> and <font color="blue">uncertainties</font>, such as those disclosed in this document</td>
    </tr>
    <tr>
      <td>We do not intend, and undertake <font color="blue">no obligation</font>, to update any forward-looking     statement</td>
    </tr>
  </tbody>
</table>